"You can rest assured that any big pharma that has looked at Brilacidin has a better understanding of it's potential, both in the clinic and in the market, than does Leo or anyone at IPIX or on these boards." I will say the big companies have the same understanding as Ipix on Brilacidin potential. For me the problem is not the understanding on potential. It is the fair price that must be paid for this potential.
"Take from that what you will. When our own CEO is investing in lasers instead of our pharma pipeline it tells you all you need to know." Could Ipix complete a Phase 2 or 3 test with USD$4 million? Of course this is silly. Some say Mr. Ehrlich would hold all of Ipix cash to pay only his salary. Of course this is also silly. Do you have any clue what Ipix has invested in? Okay I agree Squalus Medical needs to get their dam website update finished. But they are busy hiring new people.
News 
Market Data 
Discover 
